Tumor necrosis factor stimulates matrix metalloproteinase 9 secretion from cultured human chorionic trophoblast cells through TNF receptor 1 signaling to IKBKB-NFKB and MAPK1/3 pathway

Biology of Reproduction

Volumn 83, Issue 3, 2010, Pages 481-487

  Li, Wei ^a   Li, Han ^a   Bocking, Alan D ^a   Challis, John R G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Human chorionic trophoblast cells; Matrix metalloproteinase; Signaling pathway; TNF

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; GELATINASE B; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 10; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 9; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTRALIZING ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY 1A; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY 1B; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; ENZYME PHOSPHORYLATION; ENZYME RELEASE; FETUS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INFLAMMATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TROPHOBLAST; WESTERN BLOTTING; ZYMOGRAPHY;

ANALYSIS OF VARIANCE; ANTIBODIES, NEUTRALIZING; BLOTTING, WESTERN; CELLS, CULTURED; HUMANS; I-KAPPA B KINASE; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PHOSPHORYLATION; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TROPHOBLASTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956124161     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.109.082578     Document Type: Article

References (28)

1. Romero R, Sirtori M, Oyarzun E, Avila C, Mazor M, Callahan R. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol 1989; 161:817-824.
2. Geopfert AR, Goldenberg RL. Prediction of prematurity. Curr Opin Obstet Gynecol 1996; 8:417-427.
3. Robertson SA, Seamark RF, Guilbert L, Wegmann TG. The role of cytokines in gestation. Crit Rev Immunol 1994; 14:239-292.
4. Hillier SL, Witkin SS, Krohn MA, Watts KH, Kiviat NB, Eschenbach DA. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis and chorioamnion infection. Obstet Gynecol 1993; 81:941-948.
5. Gravett MG, Novy MJ, Rosenfeld RG, Reddy AP, Jacob T, Turner M, McCormack A, Lapidus JA, Hitti J, Eschenbach DA, Roberts CT Jr, Nagalla SR. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA 2004; 292:462-469. (Pubitemid 38988955)
6. Romero R, Mazor M, Sepulveda W, Avila C, Copeland D, Williams J. Tumor necrosis factor in preterm and term labor. Am J Obstet Gynecol 1992; 166:1576-1587.
7. Adams KM, Persing D, Novy MJ, Sadowsdy DW, Gravett MG. Pretreatment with Toll-like receptor 4 antagonist inhibits lipopolysaccharide-induced preterm uterine contractility, cytokines, and prostaglandins in rhesus monkeys. Reproductive Sciences 2008; 15:121-127. (Pubitemid 351903538)
8. Silver R, Lohner W, Daynes R, Mitchell M, Branch D. Lipopolysaccharide- induced fetal death: the role of tumor-necrosis factor-alpha. Biol Reprod 1994; 50:1108-1112. (Pubitemid 24116047)
9. So T, Ito A, Sato T, Mori Y, Hirakawa S. Tumor necrosis factor-alpha stimulates the biosynthesis of matrix metalloproteinases and plasminogen activator in cultured human chorionic cells. Biol Reprod 1992; 46:772-778.
10. Fortunato SJ, Menon R, Lombardi SJ. Role of tumor necrosis factor-alpha in the premature rupture of membranes and preterm labor pathways. Am J Obstet Gynecol 2002; 187:1159-1162. (Pubitemid 35397450)
11. Oner C, Schatz F, Kizilay G, Murk WK, Buchwalder LF, Kayisli U, Arici A, Lockwood CJ. Progestin-inflammatory cytokine interactions affect matrix metalloproteinase-1 and -3 expression in term decidual cells: implications for treatment of chorioamnionitis-induced preterm delivery. J Clin Endocrinol Metab 2008; 93:252-259.
12. McIntyre KW, Shuster DJ, Gillooly KM, Dambach DM, Pattoli MA, Lu P, Zhou XD, Qiu Y, Zusi FC, Burke JR. A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice. Arthritis Rheum 2003; 48:2652-2659.
13. Han Z, Boyle DI, Chang I, Bennett B, Karin M, Yang L, Manning AM, Firestein GS. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 2001; 108:73-81. (Pubitemid 32634924)
14. MacEwan DJ. TNF ligands and receptors-a matter of life and death. Br J Pharmacol 2002; 135:855-875. (Pubitemid 34214444)
15. Bradley JR, Pober JS. Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 2001; 20:6482-6491. (Pubitemid 32977853)
16. Cohen M, Meisser A, Haenggeli L, Bischof P. Involvement of MAPK pathway in TNF-alpha-induced MMP9 expression in human trophoblastic cells. Mol Hum Reprod 2006; 12:225-232. (Pubitemid 43779073)
17. Sun K, Yang K, Challis JRG. Differential regulation of 11β-hydroxysteroid dehydrogenase type I and II by nitric oxide in cultured human placental syncytiotrophoblast and chorionic cell preparation. Endocrinology 1997; 138:4912-4920. (Pubitemid 27460931)
18. Fisher SJ, Werb Z. The catabolism of extracellular matrix components. In: Haralson MA, Hassell JR (eds.), Extracellular Matrix: A Practical Approach. Oxford: IRL Press; 1995:260-287.
19. Burvall K, Palmberg L, Larsson K. Expression of TNF alpha and its receptors R1 and R2 in human alveolar epithelial cells exposed to organic dust and the effects of 8-bromo-cAMP and protein kinase A modulation. Inflamm Res 2005; 54:281-288. (Pubitemid 41185489)
20. Horie R, Gattei V, Ito K, Imajo-Ohmi S, Tange T, Miyauchi J, Pinto A, Degan M, De Iuliis A, Tassan Mazzocco F, Rossi FM, Higashihara M, Watanabe T. Frequent expression of the variant CD30 in human malignant myeloid and lymphoid neoplasms. Am J Pathol 1999; 155:2029-2041.
21. Raghav SK, Gupta B, Agrawal C, Chaturvedi VP, Das HR. Expression of TNF alpha and related signaling molecules in the peripheral blood mononuclear cells of rheumatoid arthritis patients. Mediators Inflamm 2006; 2006:1-5.
22. Liu ZG, Han J. Cellular responses to tumor necrosis factor. Curr Issues Mol Biol 2001; 3:79-90.
23. Duckett CS, Thompson CB. CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and control of cell survival. Genes Dev 1997; 11:2810-2821.
24. Holvoet S, Vincent C, Schmitt D, Serres M. The inhibition of MAPK pathway is correlated with downregulation of MMP9 secretion induced by TNF-alpha in human keratinocytes. Exp Cell Res 2003; 290:108-119.
25. Moon SK, Cha BY, Kim CH. MAPK1/3 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP1: involvement of the ras dependent pathway. J Cell Physiol 2004; 198:417-427.
26. Wiehler S, Cuvelier SL, Chakrabarti S, Patel KD. p38 MAP Kinase regulates rapid matrix metalloproteinase-9 release from eosinophils. Biochem Biophys Res Commun 2004; 315:463-470.
27. Schwabe RF, Sakurai H. IKBKB phosphorylates p65 at S468 in transactivation domain 2. FASEB J 2005; 19:1758-1760.
28. Luedde T, Assmus U, Wustefeld T, Meyer zu Vilsendorf A, Roskams T, Schmidt-Supprian M, Rajewsky K, Brenner DA, Manns MP, Pasparakis M, Trautwein C. Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. J Clin Invest 2005; 115:849-859.